Patents by Inventor Kenji Soejima
Kenji Soejima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11186630Abstract: A human antibody which comprises a complementarity determining region of an H chain consisting of the amino acid sequence as shown in SEQ ID NOs: 1 to 3 and a complementarity determining region of an L chain consisting of the amino acid sequence as shown in SEQ ID NOs: 4 to 6. The human antibody of the present invention has the activity to specifically bind to transthyretin (TTR) with structural change and the activity to inhibit fibrillization of TTR and is a human antibody suitable for application to human body.Type: GrantFiled: February 6, 2020Date of Patent: November 30, 2021Assignee: KM BIOLOGICS CO., LTD.Inventors: Masaharu Torikai, Akihiko Hosoi, Tomoyo Takeo, Masayo Ueno, Kenji Soejima, Toshihiro Nakashima, Yukio Ando, Hirofumi Jono, Yu Su, Mineyuki Mizuguchi
-
Publication number: 20200181250Abstract: A human antibody which comprises a complementarity determining region of an H chain consisting of the amino acid sequence as shown in SEQ ID NOs: 1 to 3 and a complementarity determining region of an L chain consisting of the amino acid sequence as shown in SEQ ID NOs: 4 to 6. The human antibody of the present invention has the activity to specifically bind to transthyretin (TTR) with structural change and the activity to inhibit fibrillization of TTR and is a human antibody suitable for application to human body.Type: ApplicationFiled: February 6, 2020Publication date: June 11, 2020Applicant: KM Biologics Co., Ltd.Inventors: Masaharu TORIKAI, Akihiko HOSOI, Tomoyo TAKEO, Masayo UENO, Kenji SOEJIMA, Toshihiro NAKASHIMA, Yukio ANDO, Hirofumi JONO, Yu SU, Mineyuki MIZUGUCHI
-
Patent number: 10604562Abstract: A humanized antibody which comprises a complementarity determining region of an H chain consisting of the amino acid sequence as shown in SEQ ID NOs: 1 to 3 and a complementarity determining region of an L chain consisting of the amino acid sequence as shown in SEQ ID NOs: 4 to 6. The humanized antibody of the present invention has the activity to specifically bind to transthyretin (TTR) with structural change and the activity to inhibit fibrillization of TTR and is a humanized antibody suitable for application to human body.Type: GrantFiled: January 23, 2015Date of Patent: March 31, 2020Assignees: KM BIOLOGICS CO., LTD., NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITYInventors: Akihiko Hosoi, Masaharu Torikai, Tomoyo Takeo, Masayo Ueno, Hirofumi Higuchi, Kenji Soejima, Toshihiro Nakashima, Yukio Ando, Hirofumi Jono, Yu Su
-
Patent number: 10597440Abstract: A human antibody which comprises a complementarity determining region of an H chain consisting of the amino acid sequence as shown in SEQ ID NOs: 1 to 3 and a complementarity determining region of an L chain consisting of the amino acid sequence as shown in SEQ ID NOs: 4 to 6. The human antibody of the present invention has the activity to specifically bind to transthyretin (TTR) with structural change and the activity to inhibit fibrillization of TTR and is a human antibody suitable for application to human body.Type: GrantFiled: January 23, 2015Date of Patent: March 24, 2020Assignee: KM BIOLOGICS CO., LTD.Inventors: Masaharu Torikai, Akihiko Hosoi, Tomoyo Takeo, Masayo Ueno, Kenji Soejima, Toshihiro Nakashima, Yukio Ando, Hirofumi Jono, Yu Su, Mineyuki Mizuguchi
-
Patent number: 10570199Abstract: The present invention relates to a human anti-human IL-18 antibody which reacts with human interleukin-18 (human IL-18) and does not react with a K53A variant of human IL-18.Type: GrantFiled: November 18, 2013Date of Patent: February 25, 2020Assignee: KM Biologics Co., Ltd.Inventors: Hiroyuki Shimizu, Miyuki Matsumoto, Kenji Soejima, Masaharu Torikai, Toshihiro Nakashima
-
Publication number: 20190077858Abstract: The present invention relates to a human anti-human IL-18 antibody which reacts with human interleukin-18 (human IL-18) and does not react with a K53A variant of human IL-18.Type: ApplicationFiled: November 18, 2013Publication date: March 14, 2019Inventors: Hiroyuki Shimizu, Miyuki Matsumoto, Kenji Soejima, Masaharu Torikai, Toshihiro Nakashima
-
Patent number: 10171294Abstract: Consistency between a requirement for communication with respect to software in a system and a requirement for a network is maintained, without re-designing a network by the user. A requirement conversion unit (110) of a system design support device (100) generates a requirement for communication between computers based on a requirement for communication between software components included in a system, and based on identifiers of the computers in which the software components are deployed. The requirement conversion unit (110) generates a requirement for a network for connecting between the computers based on the requirement for communication between the computers.Type: GrantFiled: August 21, 2014Date of Patent: January 1, 2019Assignee: NEC CORPORATIONInventor: Kenji Soejima
-
Patent number: 9921882Abstract: An objective of the present invention is to construct a system in which a plurality of software components having dependencies are deployed dispersedly on a plurality of processing devices. The information system includes a deployment device (100) and a plurality of processing devices (200). A scheduler (210) of the processing device (200) determine whether there is a deployment task satisfying an execution condition in task information (231) on the basis of a termination event of a deployment task. When there is a deployment task satisfying the execution condition, the scheduler (210) executes the deployment task and transmits a termination event of the deployment task to the deployment device (100). An event processing unit (130) of the deployment device (100) transmits the termination event of the deployment task to a notification destination processing device (200) referring to event information (141).Type: GrantFiled: April 15, 2014Date of Patent: March 20, 2018Assignee: NEC CORPORATIONInventor: Kenji Soejima
-
Publication number: 20160347832Abstract: A humanized antibody which comprises a complementarity determining region of an H chain consisting of the amino acid sequence as shown in SEQ ID NOs: 1 to 3 and a complementarity determining region of an L chain consisting of the amino acid sequence as shown in SEQ ID NOs: 4 to 6. The humanized antibody of the present invention has the activity to specifically bind to transthyretin (TTR) with structural change and the activity to inhibit fibrillization of TTR and is a humanized antibody suitable for application to human body.Type: ApplicationFiled: January 23, 2015Publication date: December 1, 2016Applicants: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE, NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSIT YInventors: Akihiko HOSOI, Masaharu TORIKAI, Tomoyo TAKEO, Masayo UENO, Hirofumi HIGUCHI, Kenji SOEJIMA, Toshihiro NAKASHIMA, Yukio ANDO, Hirofumi JONO, Yu SU
-
Publication number: 20160340419Abstract: A human antibody which comprises a complementarity determining region of an H chain consisting of the amino acid sequence as shown in SEQ ID NOs: 1 to 3 and a complementarity determining region of an L chain consisting of the amino acid sequence as shown in SEQ ID NOs: 4 to 6. The human antibody of the present invention has the activity to specifically bind to transthyretin (TTR) with structural change and the activity to inhibit fibrillization of TTR and is a human antibody suitable for application to human body.Type: ApplicationFiled: January 23, 2015Publication date: November 24, 2016Applicant: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTEInventors: Masaharu TORIKAI, Akihiko HOSOI, Tomoyo TAKEO, Masayo UENO, Kenji SOEJIMA, Toshihiro NAKASHIMA, Yukio ANDO, Hirofumi JONO, Yu SU, Mineyuki MIZUGUCHI
-
Publication number: 20160197779Abstract: Consistency between a requirement for communication with respect to software in a system and a requirement for a network is maintained, without re-designing a network by the user. A requirement conversion unit (110) of a system design support device (100) generates a requirement for communication between computers based on a requirement for communication between software components included in a system, and based on identifiers of the computers in which the software components are deployed. The requirement conversion unit (110) generates a requirement for a network for connecting between the computers based on the requirement for communication between the computers.Type: ApplicationFiled: August 21, 2014Publication date: July 7, 2016Inventor: Kenji Soejima
-
Patent number: 9342382Abstract: Internal processes of specified components are connected to each other when an application is executed regardless of interface definition between the components and a new process is executed. A program processing apparatus (100) includes an aspect application unit (102) which generates a routing unit (201) and a connector unit (301) and applies the routing unit (201) and the connector unit (301), respectively to a component (200) and a component (300) which are included in an activated program, and a configuration management unit (101) which causes the routing unit (201) applied to the component (200) and the connector unit (301) applied to the component (300) to establish a communication connection with each other and causes the component (300) to send a process result of an process instruction in the component (300) to the component (200) through the established communication connection.Type: GrantFiled: February 2, 2011Date of Patent: May 17, 2016Assignee: NEC CORPORATIONInventor: Kenji Soejima
-
Publication number: 20160034315Abstract: An objective of the present invention is to construct a system in which a plurality of software components having dependencies are deployed dispersedly on a plurality of processing devices. The information system includes a deployment device (100) and a plurality of processing devices (200). A scheduler (210) of the processing device (200) determine whether there is a deployment task satisfying an execution condition in task information (231) on the basis of a termination event of a deployment task. When there is a deployment task satisfying the execution condition, the scheduler (210) executes the deployment task and transmits a termination event of the deployment task to the deployment device (100). An event processing unit (130) of the deployment device (100) transmits the termination event of the deployment task to a notification destination processing device (200) referring to event information (141).Type: ApplicationFiled: April 15, 2014Publication date: February 4, 2016Applicant: NEC CorporationInventor: Kenji SOEJIMA
-
Publication number: 20150277940Abstract: A program setting device to allow setting items of a program to be flexibly defined in accordance with a level of skill of a user is provided. A program setting device (100) includes a concretization logic execution unit (121) and a set value determination unit (120). The concretization logic execution unit (121) executes a concretization logic (311) for calculating a concrete setting item (302) which is a setting item specific to each of a plurality of implementations of a program from an abstract setting item (202) which is a setting item common to the plurality of implementations of the program.Type: ApplicationFiled: November 14, 2013Publication date: October 1, 2015Applicant: NEC CorporationInventor: Kenji Soejima
-
Patent number: 9109217Abstract: An enhanced disintegrin-like domain, and metalloprotease, with an isolated human thrombospondin type 1 motif, member 13 (ADAMTS-13) that includes substitutions at one or more positions in the isolated human ADAMTS-13.Type: GrantFiled: October 30, 2014Date of Patent: August 18, 2015Assignee: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTEInventor: Kenji Soejima
-
Patent number: 9003370Abstract: There are provided: a test executing section which generates a plurality of logs when executing a coverage test for an application based on an inputted parameter; and a result processing section which generates a point candidate report based on the plurality of logs. The plurality of logs respectively indicate a call stack of a method designating the parameter as an argument among a plurality of methods called during execution of the coverage test. The call stack indicates a location on the application, in which a call of the method is defined. The point candidate report indicates a candidate for a point in the application, for which a modification is necessary when a dispatch of process is executed based on the parameter.Type: GrantFiled: March 2, 2011Date of Patent: April 7, 2015Assignee: NEC CorporationInventor: Kenji Soejima
-
Publication number: 20150050716Abstract: An enhanced disintegrin-like domain, and metalloprotease, with an isolated human thrombospondin type 1 motif, member 13 (ADAMTS-13) that includes substitutions at one or more positions in the isolated human ADAMTS-13.Type: ApplicationFiled: October 30, 2014Publication date: February 19, 2015Applicant: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTEInventor: Kenji SOEJIMA
-
Publication number: 20150033204Abstract: A construction procedure of a system which is constructed by performing operations of plural types with respect to each of plural program modules is generated. A system-construction-procedure generating device (100) includes a dependency relationship storing unit (111), an operating procedure storing unit (112), and an operating procedure generating unit (102). The dependency relationship storing unit (111) stores dependency relationship information (121) indicating a dependency relationship (123) for each of one or more pairs of operations among a plurality of operations each expressed with a combination of one of a plurality of program modules and one of a plurality of operation types, the plurality of operations being required for system construction. The operating procedure storing unit (112) stores a procedure sequence (122) indicating a sequence for performing each of the plurality of operations.Type: ApplicationFiled: February 18, 2013Publication date: January 29, 2015Applicant: NEC CORPORATIONInventor: Kenji Soejima
-
Patent number: 8906661Abstract: An enhanced disintegrin-like domain, and metalloprotease, with an isolated human thrombospondin type 1 motif, member 13 (ADAMTS-13) that includes substitutions at one or more positions in the isolated human ADAMTS-13.Type: GrantFiled: January 28, 2014Date of Patent: December 9, 2014Assignee: The Chemo-Sero-Therapeutic Research InstituteInventor: Kenji Soejima
-
Publication number: 20140193881Abstract: An enhanced disintegrin-like domain, and metalloprotease, with an isolated human thrombospondin type 1 motif, member 13 (ADAMTS-13) that includes substitutions at one or more positions in the isolated human ADAMTS-13.Type: ApplicationFiled: January 28, 2014Publication date: July 10, 2014Applicant: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTEInventor: Kenji SOEJIMA